Comparing ability and norm-referenced scores as clinical trial outcomes for neurodevelopmental disabilities: a simulation study

被引:12
|
作者
Farmer, Cristan [1 ]
Thurm, Audrey [1 ]
Troy, Jesse D. D. [2 ]
Kaat, Aaron J. J. [3 ]
机构
[1] Natl Inst Mental Hlth, Neurodev & Behav Phenotyping Serv, Bethesda, MD 20892 USA
[2] Duke Univ, Dept Biostat & Bioinformat, Sch Med, Durham, NC USA
[3] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
基金
美国国家卫生研究院;
关键词
Ability score; Growth scale value; Rasch analysis; Item response theory; Neurodevelopmental disability; Rare genetic condition; Floor effect; Clinical trials; Clinical outcome assessment; Endpoints; ITEM RESPONSE THEORY;
D O I
10.1186/s11689-022-09474-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BackgroundFor genetic conditions associated with neurodevelopmental disorder (GCAND), developmental domains such as motor ability, thinking and learning, social abilities, and communication are potential intervention targets. Performance on measures of developmental concepts can be expressed using several types of scores. Norm-referenced scores are intended for the diagnostic context, allowing for the identification of impairment relative to age-based expectations, and can exhibit dramatic floor effects when used in individuals with more significant limitations. Person ability scores, which are derived via Rasch analysis or item response theory, are available on many standardized tests and are intended to measure within-person change. However, they have not been used or evaluated as primary endpoints in GCAND clinical trials. In this study, we simulated a series of parallel-arm clinical trials under several chronological age and impairment conditions, to compare empirically the power and type I error rate of operationalizing test performance using ability scores rather than norm-referenced scores.ResultsUsing the Vineland Adaptive Behavior Scales as the example, we demonstrated an advantage in statistical power of ability scores over norm-referenced scores at extreme levels of impairment. This advantage was at least partially driven by floor effects in norm-referenced scores. For simulated conditions where impairment was less severe, ability scores outperformed norm-referenced scores, but they were more similar. The type I error rate closely approximated the nominal type I error rate of 5% for both scores.ConclusionThe results of this simulation demonstrate a substantial power and interpretative advantage of ability scores over norm-referenced scores for studies of GCAND that will enroll participants with high levels of impairment. These results are expected to generalize to studies of developmental concepts, regardless of the etiology or specific test. However, the relative advantage of ability scores is expected to be even greater for tests with a higher floor than the Vineland.
引用
收藏
页数:9
相关论文
共 4 条
  • [1] Comparing ability and norm-referenced scores as clinical trial outcomes for neurodevelopmental disabilities: a simulation study
    Cristan Farmer
    Audrey Thurm
    Jesse D. Troy
    Aaron J. Kaat
    Journal of Neurodevelopmental Disorders, 15
  • [2] Person Ability Scores as an Alternative to Norm-Referenced Scores as Outcome Measures in Studies of Neurodevelopmental Disorders
    Farmer, Cristan A.
    Kaat, Aaron J.
    Thurm, Audrey
    Anselm, Irina
    Akshoomoff, Natacha
    Bennett, Amanda
    Berry, Leandra
    Bruchey, Aleksandra
    Barshop, Bruce A.
    Berry-Kravis, Elizabeth
    Bianconi, Simona
    Cecil, Kim M.
    Davis, Robert J.
    Ficicioglu, Can
    Porter, Forbes D.
    Wainer, Allison
    Goin-Kochel, Robin P.
    Leonczyk, Caroline
    Guthrie, Whitney
    Koeberl, Dwight
    Love-Nichols, Jamie
    Mamak, Eva
    Mercimek-Andrews, Saadet
    Thomas, Rebecca P.
    Spiridigliozzi, Gail A.
    Sullivan, Nancy
    Sutton, Vernon R.
    Udhnani, Manisha D.
    Waisbren, Susan E.
    Miller, Judith S.
    AJIDD-AMERICAN JOURNAL ON INTELLECTUAL AND DEVELOPMENTAL DISABILITIES, 2020, 125 (06): : 475 - 480
  • [3] Identification of neurodevelopmental disabilities in underserved children using telehealth (INvesT): Clinical trial study design
    Ciccia, Angela Hein
    Roizen, Nancy
    Garvey, Matt
    Bielefeld, Roger
    Short, Elizabeth J.
    CONTEMPORARY CLINICAL TRIALS, 2015, 45 : 226 - 232
  • [4] Joint models inform the longitudinal assessment of patient-reported outcomes in clinical trials: a simulation study and secondary analysis of the restrictive Vs. liberal fluid therapy for major abdominal surgery (RELIEF) randomized controlled trial
    Daza, Julian F.
    Mitani, Aya A.
    Alibhai, Shabbir M. H.
    Smith, Peter M.
    Kennedy, Erin D.
    Shulman, Mark A.
    Myles, Paul S.
    Wijeysundera, Duminda N.
    JOURNAL OF CLINICAL EPIDEMIOLOGY, 2024, 176